trending Market Intelligence /marketintelligence/en/news-insights/trending/aiYFmtmajuGKOduVtF9_1A2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Edwards Lifesciences closes Valtech Cardio acquisition

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Edwards Lifesciences closes Valtech Cardio acquisition

Edwards Lifesciences Corp. completed the acquisition of Israel-based Valtech Cardio Ltd. for $340 million in stock and cash.

In addition, the deal provides for the potential of up to $350 million in prespecified milestone-driven payments over the next 10 years.

Valtech is the developer of the cardioband system for transcatheter repair of the mitral and tricuspid valves.